Lymphosarcoma: virus-induced thymic-independent disease in mice.

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Cancer Research

• Publication date

  1970-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 4318922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

  1970cited by this paper
• A new tumor inducing variant of moloney leukemia virus. Abstr.

  1969cited by this paper
• Pathogenesis of murine leukemia.

  1966cited by this paper
• An electron microscopic study of a virus-induced murine sarcoma (Moloney).

  1966cited by this paper
• HISTOGENESIS OF THYMIC LYMPHOMA INDUCED BY A MURINE LEUKEMIA VIRUS (RICH).

  1964cited by this paper
• THE HISTOGENESIS OF GROSS'S VIRAL INDUCED MOUSE LEUKEMIA.

  1963cited by this paper
• The murine leukemias.

  1962influential reference
• Pathogenesis of a virus-induced leukemia in mice.

  1961cited by this paper
• Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations.

  1960cited by this paper
• Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms.

  1954cited by this paper
• Histological Changes Preceding Spontaneous Lymphatic Leukemia in Mice.

  1943cited by this paper
• Induction of Leukemia in Mice by Methylcholanthrene and X-Rays

  1942cited by this paper

• Non-receptor tyrosine kinase c-Abl downstream of C-type lectin receptors regulates innate antifungal immunity through c-Cbl/MAPK pathway

  2026cites this paper
• An aminocaproic acid-grafted chitosan derivative with superior antibacterial and hemostatic properties for the prevention of secondary bleeding.

  2023cites this paper
• Abl kinases can function as suppressors of tumor progression and metastasis

  2023cites this paper
• Comprehensive transcriptomic and co-expression analysis of ABL1 gene and molecularly targeted drugs in hepatocellular carcinoma based on multi-database mining

  2022cites this paper
• Abelson tyrosine kinase controls BCR signalling and B‐cell differentiation by promoting B‐cell metabolism

  2022cites this paper
• Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade

  2021cites this paper
• The Role of Cytokines Produced via the NLRP3 Inflammasome in Mouse Macrophages Stimulated with Dental Calculus in Osteoclastogenesis

  2021cites this paper
• Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to

  2020cites this paper
• Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review.

  2020cites this paper
• Imatinib

  2020cites this paper
• NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation

  2020cites this paper
• Molecular docking and pharmacophoric modelling of 1,5-disubstituted tetrazoles as inhibitors of two proteins present in cancer, the ABL and the mutated T315I kinase

  2020cites this paper
• Amplification of the c-abl Oncogene in Chronic Myelogenous Leukemia

  2020cites this paper
• Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis

  2020cites this paper
• Molecular genetic disorders in acute leukemia as a basis for the development of diagnostic tests (literature review)

  2020cites this paper
• Molecular Diagnostics in Cancer: A Fundamental Component of Precision Oncology

  2019cites this paper
• Relationships between Abelson tyrosine kinase (c-abl) and spindle during meiotic division in mouse oocyte in vitro

  2019cites this paper
• Targeting autophagy in chronic myeloid leukemia through inhibition of the core autophagy protein ATG4B

  2018cites this paper
• Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation

  2018cites this paper
• Comparative Characterization of Osteoclasts Derived From Murine Bone Marrow Macrophages and RAW 264.7 Cells Using Quantitative Proteomics

  2018cites this paper
• The Abelson tyrosine kinase (c-Abl) localization in preimplantation mouse development.

  2017cites this paper
• Docking studies of 1,5-disubtituted tetrazoles analogs of the anticancer drug imatinib as probable inhibitors of the ABL kinase and the T315I mutant kinase

  2017cites this paper
• A Virtual Screening Approach for the Identification of High Affinity Small Molecules Targeting BCR-ABL1 Inhibitors for the Treatment of Chronic Myeloid Leukemia.

  2017cites this paper
• Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases

  2017cites this paper
• The ba/f3 transformation assay: characterization of a novel csf2rb-activating variant, and the discovery of acquired mutations in ba/f3 cells

  2017cites this paper
• Imatinib: Basic Results

  2017cites this paper
• Multifunctional Abl kinases in health and disease

  2016cites this paper
• Chronic myeloid leukemia: reminiscences and dreams

  2016cites this paper
• Systemic Review on Chronic Myeloid Leukemia: Therapeutic Targets, Pathways and Inhibitors

  2015cites this paper
• Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Chronic Myeloid Leukaemia

  2015cites this paper
• Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.

  2015cites this paper
• Elucidation of Proto-Oncogene C-Abl Function with the Use of Mouse Models and the Disease Model of Chronic Myeloid Leukemia

  2015cites this paper
• Influence du microenvironnement inflammatoire sur la sénescence contrôlée par la réponse aux dommages à l'ADN, et sa régulation par l’induction du stress à la chromatine

  2015cites this paper
• Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer

  2015cites this paper
• [History of chronic myeloid leukemia: a paradigm in the treatment of cancer].

  2014cites this paper
• Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity

  2014cites this paper
• DIFFERENTIAL EFFECTS OF MOUSE APOBEC3 AFTER INCORPORATION INTO MURINE LEUKEMIA VIRUSES

  2014cites this paper
• Characterization of the Molecular Signal Transduction Pathway of the Tyrosine Kinase Abl1 in Response to Genotoxic Stress

  2013cites this paper
• Gads is a Regulator of Normal and Leukemic Hematopoiesis

  2013cites this paper
• [Targeted therapy: old and new possibilities].

  2013cites this paper
• Role of ABL family kinases in cancer: from leukaemia to solid tumours

  2013cites this paper
• Cancérologie : cibles et traitements ciblés Leucémie myéloı̈de chronique : « archétype » de l ’ impact des traitements ciblés Chronic myeloid leukemia : ‘ ‘ Archetype ’ ’ of the impact of targeted therapies

  2012cites this paper
• Rapid neuronal signaling cascades initiated by corticosterone

  2012cites this paper
• [Chronic myeloid leukemia: "archetype" of the impact of targeted therapies].

  2012cites this paper
• Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

  2012cites this paper
• Setting the Paradigm of Targeted Drugs for the Treatment of Cancer: Imatinib and Nilotinib, Therapies for Chronic Myelogenous Leukemia

  2012cites this paper
• Genetic aberrations in patients with leukaemia and their impact on prognosis

  2012cites this paper
• Extensive Gene-Specific Translational Reprogramming in a Model of B Cell Differentiation and Abl-Dependent Transformation

  2012cites this paper
• Functional Study of the Threonine Phosphorylation and the Transcriptional Coactivator Role of P68 RNA Helicase

  2012cites this paper
• Molecular Biology of Chronic Myeloid Leukemia

  2012cites this paper
• The abelson tyrosine kinase (c-Abl) expression on the mouse uterus and placenta during gestational period

  2011cites this paper
• A Correction to the Review Titled: “ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity” by J. Colicelli

  2011cites this paper
• Pathogenesis of early leukemia and lymphoma

  2011cites this paper
• Abl family of tyrosine kinases and microbial pathogenesis.

  2011cites this paper
• INTERACTIONS BETWEEN THE GLYCOSYLATED GAG PROTEIN OF A MURINE LEUKEMIA VIRUS AND MURINE APOBEC3: NOVEL INSIGHTS INTO HOW A MURINE LEUKEMIA VIRUS COUNTERACTS A RESTRICTION FACTOR

  2011cites this paper
• AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders

  2011cites this paper
• ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity

  2010cites this paper
• The role of type I interferon in v-abl induced leukemia

  2010cites this paper
• Genexpressionsanalysen der gesunden hämatopoetischen Stamm- und Progenitorzellen bei Patienten mit chronischer myeloischer Leukämie unter Therapie mit Imatinib

  2010cites this paper
• Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-κB

  2010cites this paper
• Chronic Myeloid Leukemia: Pathophysiology and Therapeutics

  2010cites this paper
• Overview of Retrovirology

  2010cites this paper
• Biology-driven cancer drug development: back to the future

  2010cites this paper
• From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and Beyond.

  2010cites this paper
• Chronic myeloid leukemia: a historical perspective.

  2010cites this paper
• Deregulation of Signal Transduction Pathways by Oncogenic Retroviruses

  2010cites this paper
• Avaliação dos efeitos imunomoduladores e citotóxicos de polissacarídeos de Chorisia Speciosa e Hymenaea Courbaril

  2010cites this paper
• In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.

  2010cites this paper
• Untersuchungen zur Molekulargenetik der akuten lymphatischen Leukämie des Erwachsenenalters

  2010cites this paper
• Targeting Transduction Pathways for Research and Medical Intervention

  2009cites this paper
• Investigating the SRC kinase HCK functions in Chronic Myelogenous Leukemia using chemical genetics methods.

  2009cites this paper
• Tumor Growth and Cell Proliferation

  2009cites this paper
• αvβ5 and related receptors in human B lymphocyte development.

  2008cites this paper
• Following the cytokine signaling pathway to leukemogenesis: a chronology.

  2008cites this paper
• The history of myeloproliferative disorders: before and after Dameshek

  2008cites this paper
• Translation of the Philadelphia chromosome into therapy for CML.

  2008cites this paper
• Brief historical sketch of chromosomal translocations and tumors.

  2008cites this paper
• Entwicklung eines Kleintiermodells zurEvaluierung von Impfstoffen gegen Retroviren

  2007cites this paper
• Bcr-Abl and Signal Transduction

  2007cites this paper
• Chronic Myeloid Leukemia — A Brief History

  2007cites this paper
• Treatment for chronic myelogenous leukemia: the long road to imatinib.

  2007cites this paper
• Chronic myelogenous leukemia and genetic events at 9q34

  2007cites this paper
• Viral Oncogene Expression during Differentiation of Abelson Virus-infected Murine Promonocytic Leukemia Cells1

  2006cites this paper
• Chronic myeloid leukemia: diagnosis and treatment.

  2006cites this paper
• Targeting the oncogenic tyrosine kinase NPM-ALK in lymphoma: the role of murine models in defining pathogenesis and treatment options.

  2006cites this paper
• A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus.

  2006cites this paper
• Abl Family Kinases in Mammalian Development

  2006cites this paper
• Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?

  2006cites this paper
• Proviral integration of an Abelson-murine leukemia virus deregulates BKLF-expression in the hypermutating pre-B cell line 18-81.

  2005cites this paper
• Molecular evolutionary rates of oncogenes

  2005influential citation
• Targeted therapy: For kids, too

  2005cites this paper
• Oncogenes as Novel Targets for Cancer Therapy (Part I)

  2005cites this paper
• Oncogenes as Novel Targets for Cancer Therapy (Part IV)

  2005cites this paper
• Abl: the prototype of oncogenic fusion proteins.

  2004cites this paper
• Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.

  2004cites this paper
• Haemopoiesis, leukaemia & imatinib: c-fms, a novel target for small molecule inhibitor therapy.

  2004cites this paper
• Hemopoietic stem cells and target cells in murine-virus-induced leukemias

  2004cites this paper
• CHAPTER 24 – Classification and Characteristics of Mouse B Cell—Lineage Lymphomas

  2004cites this paper
• The BCR-ABL story: bench to bedside and back.

  2004cites this paper
• Imatinib as a paradigm of targeted therapies.

  2004cites this paper